ICHOR Vascular develops a percutaneous arterial embolectomy system for the treatment of critical limb ischemia.
ICHOR Vascular has raised $2.9M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in February 2024.
ICHOR Vascular's investors include IrishAngels, Berkeley Angel Network.
ICHOR Vascular is headquartered in Miramar Beach, United States.
ICHOR Vascular develops a percutaneous arterial embolectomy system for the treatment of critical limb ischemia.
ICHOR Vascular is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"ICHOR Vascular — Funding & Investors." VCBacked, February 5, 2024, https://www.vcbacked.co/company/ichor-vascular. Accessed August 14, 2026.
VCBacked. (2024). ICHOR Vascular — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/ichor-vascular
{{cite web |title=ICHOR Vascular — Funding & Investors |url=https://www.vcbacked.co/company/ichor-vascular |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated